Joseph Nixon

Director of Finance/CFO at Locus Biosciences, Inc.

Consumer Services

Commercial Services

Technology Services

Profile

Joseph Nixon is currently the Director at Bioaesthetics Corp.
and the Chief Financial Officer at Locus Biosciences, Inc. He received his undergraduate degree from Case Western Reserve University and his MBA from Harvard Business School.

Joseph Nixon active positions

Companies	Position	Start
Bioaesthetics Corp. Bioaesthetics Corp. Miscellaneous Commercial ServicesCommercial Services Bioaesthetics Corp. provides biotechnology health care services. The company was founded by Nicholas C. Pashos and is headquartered in New Orleans, LA.	Director/Board Member	2023-08-22
Locus Biosciences, Inc. Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC.	Director of Finance/CFO	-

All active positions of Joseph Nixon

Training of Joseph Nixon

Case Western Reserve University	Undergraduate Degree
Harvard Business School	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Joseph Nixon's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Bioaesthetics Corp. Bioaesthetics Corp. Miscellaneous Commercial ServicesCommercial Services Bioaesthetics Corp. provides biotechnology health care services. The company was founded by Nicholas C. Pashos and is headquartered in New Orleans, LA.	Commercial Services
Locus Biosciences, Inc. Locus Biosciences, Inc. Packaged SoftwareTechnology Services Locus Biosciences, Inc. develops CRISPR-engineered precision antibacterial products for antibiotic-resistant bacterial infections and microbiome-related disease. The firm offers CRISPR-engineered bacteriophage and CRISPR-Cas3 phage. The company was founded by Charles Gersbach, Dave Ousterout, Chase Beisel, Paul M. Garofolo, Nick Taylor, and Rodolphe Barrangou in 2015 and is headquartered in Morrisville, NC.	Technology Services